US+1 646-781-8004
Europe+44-203-868-8738
APAC+91-744-778-0008
sales@meticulousresearch.com
Resources 
    • About Us 

    • Home Report Store Antibody Production Market
    Antibody Production Market

    Antibody Production Market by Product [Bioreactors (Single use, Reusable), Chromatography, Filtration, Cell Lines, Media, Buffers, Resins], Antibody [Monoclonal, Polyclonal], Source [Mice, Rabbit], Process [Downstream, Upstream] – Global Forecast to 2031

    Report ID:MRHC - 1041086 Pages: 200 Jan-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours

    The Antibody Production Market was valued at $24.51  billion in 2023. This market is expected to reach $58.35  billion by 2031, from an estimated $27.41  billion in 2024, at a CAGR of 11.4% during the forecast period 2024-2031.

    Antibody Production Market Size & Forecast

    Antibodies have therapeutics as well as diagnostic applications. Antibodies are majorly used for therapeutics for several diseases and conditions, such as cancer, autoimmune diseases, infectious diseases, and other conditions. The production of antibodies involves processes such as the downstream process and upstream process. Antibodies can be derived from sources such as mice and rabbit, among other sources.

    The growth of this market is attributed to growing demand for targeted antibodies, increasing investments in R&D by pharma & biotech companies, growing prevalence of cancer and autoimmune diseases, increasing use of immunoassays, and advancements in bioprocessing technologies. However, the high cost of antibody production and stringent regulatory framework restrain the growth of this market.

    Furthermore, growing applications of antibodies in clinical trials and medical research, significant opportunities from developing countries, and growing risk and prevalence of infectious diseases are expected to generate growth opportunities for the players operating in this market. However, the complex nature of monoclonal antibodies poses a challenge for market stakeholders during antibody production.

    Increasing Risk and Prevalence of Infectious Diseases Presents a Significant Opportunity for Players Operating in the Antibody Production Market

    Antibodies are key to diagnosing and treating infectious diseases in the form of a detection or capture agent in an ELISA, a biomarker of interest, or a key vaccine component. The normal immune response to a viral or a microbial infection is the production of antibodies towards the antigens of the infection. Passive immunization for post-exposure prophylaxis or adjunct therapy has been successfully used for over a century to treat suspected exposure or infection against a range of diseases, such as rabies, diphtheria, tetanus, and hepatitis B. For most of these diseases, the immunoglobulin preparations administered to patients have been derived from immunized horses, immunized humans, and in some cases, from convalescent patients. Moreover, immunization with monoclonal antibodies has some advantages over active immunization with vaccines, such as protection afforded via passive immunization is immediate, and such protection can be induced in immunosuppressed individuals who are often at the highest risk of infection.

    The growing prevalence and increasing risk of outbreaks of infectious diseases is expected to drive the adoption of antibodies for immunization, further leading to the demand for their production. According to an article published in the United Nations’ Africa Renewal digital magazine in July 2022, the risk of outbreaks caused by zoonotic pathogens such as the Ebola & monkeypox viruses that originate in animals and infect humans is rising. There has been a 63.0% increase in the number of zoonotic disease outbreaks in Africa from 2012–2022 compared to 2001– 2011.

    Antibody Production Market

    Click here to: Get Free Sample Pages of this Report

    High Burden and Growing Prevalence of Cancer and Autoimmune Diseases Leads in the Demand for Antibody Production

    Cancer poses a major burden on the global population and is further estimated to increase cancer cases, leading to mortality and degradation of quality of life. For instance, by 2030 the total number of new cancer cases is estimated to account for 24.6 million from 19.3 million in 2020 (Source: International Agency for Research on Cancer). Monoclonal antibodies (mABs) are used for the treatment of cancer as mABs are a type of targeted drug therapy. These drugs recognize and find specific proteins and cancer cells and help in the inhibition of their growth. Governments and several organizations and associations strive towards making better treatments and preventing cancer in people. Similarly, pharmaceutical & biopharmaceutical companies are developing newer drugs and biologics for the treatment of cancer. Pharma & biopharma companies are developing and gaining approvals for monoclonal antibodies for cancer. For instance, according to the Antibody Society, as of 2020, 43 monoclonal antibodies were approved or under review in the European Union or the U.S. Growing cancer prevalence and initiatives towards approval and development of mABs for cancer further lead to the increased production of antibodies.

    Similarly, monoclonal antibodies are used to treat autoimmune diseases, a condition in which antibodies in an individual attack its own body, causing inflammation. Several anti-inflammatory monoclonal antibodies are used in the treatment of autoimmune diseases. For instance, monoclonal antibodies used to treat arthritis are known as tumor necrosis factor (TNF) inhibitors. TNF is a protein involved in causing inflammation and damage of rheumatoid arthritis. According to Lancet Diabetes & Endocrinology, in 2021, around 8.4 million people were affected with type-1 diabetes (one of the most common autoimmune diseases) globally. This number is estimated to increase to 13.5–17.4 million people by 2040. Also, as of 2022, around 1-1.5% of the European population (7 million) had celiac disease. (Source: European Parliament). Similarly, as of 2020, around 44 people per 100,000 population were affected with multiple sclerosis globally (Source: MS Atlas). The growing prevalence of autoimmune diseases is further expected to drive the demand for monoclonal antibodies for their treatment, driving the need for antibody production.

    Key Findings of the Global Antibody Production Market Study:

    The Instrument Segment to Dominate the Antibody Production Market in 2024

    The instrument segment is further segmented into bioreactors, chromatography systems, filtration systems, and other instruments. Antibodies are widely used as diagnostic reagents and for therapeutic purposes, and their demand is increasing extensively. To produce these antibodies in sufficient quantities for commercial use, it is necessary to raise the output by scaling up the production processes. Bioreactors allow for better control of culture conditions, which can lead to higher cell densities and increased antibody yield. This can result in fewer runs needed to manufacture the desired amount of antibody, leading to the largest share of the segment. Furthermore, the chromatography systems are crucial in the quality control and filtration of the antibodies, leading to their high adoption.

    The Monoclonal Antibodies Segment to Account for the Largest Market Share in 2024

    The factors contributing to the segment’s large share are the wide array of applications of monoclonal antibodies in therapeutics for various diseases and conditions, the growing prevalence of chronic diseases, and the growing focus of pharm & biopharma companies on the development of monoclonal antibodies-based therapeutics.

    The Mice Segment to Account for the Largest Market Share in 2024

    Due to the availability, low cost, and quick production time for mouse mAbs, humanization of mouse mAbs has been implemented on a large scale. Furthermore, mouse husbandry is easier than rabbit husbandry, and the genetic approaches to engineering antibodies through recombinant technologies are more established for mice than other animals such rabbits, making mice a preferred choice for antibody production.

    The Downstream Segment to Account for the Largest Market Share in 2024

    Downstream processing constitutes a critical step in manufacturing antibodies with regard to product purity, cost, and environmental impact. The purpose of downstream processing is to isolate, purify, and concentrate the previously synthesized antibody from the complex bulk matrix.

    Pharmaceutical & Biopharmaceutical Companies Segment to Account for the Largest Market Share in 2024

    The large share of the segment is attributed to the growing R&D investments by pharma & biotech companies, increasing demand for biological therapeutics, high prevalence of chronic diseases, and capacity & geographic expansion of production facilities by the pharma & biopharma companies. Several pharma & biopharma are taking initiatives for the expansion of their production facilities, leading to the adoption of products for antibody production. For instance, in 2022, Seagen Inc. (U.S.), a biotechnology company focused on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer, announced the building of a new biologics facility. This facility will start its production in 2024 and will include monoclonal antibody production, fill & finish, quality control labs, package & labeling, warehouse, and office space.

    Asia-Pacific: Fastest-Growing Regional Market

    In 2024, North America is expected to dominate the antibody production market, while Asia-Pacific is expected to record the highest CAGR during the forecast period. The high growth of the Asia-Pacific antibody production market is attributed to the growing pharmaceutical and biotech industry, supporting government initiatives, a large number of clinical trials conducted in the Asia-Pacific region, and growing demands and biologics for chronic & infectious diseases.

    Antibody Production Market: Key Players

    The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in this market in the last three to four years. The key players profiled in the antibody production market are Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KgaA (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Waters Corporation (U.S.), Shimadzu Corporation (Japan), Solaris Biotechnology Srl (Italy), and Infors AG (Switzerland).

    Antibody Production Market Report Summary:

    Particular

    Details

    Page No

    ~200

    Format

    PDF

    Forecast Period

    2024-2031

    Base Year

    2023

    CAGR

    11.4%

    2030 Market Size (Value)

    $58.35 billion by 2031

    Segments Covered

    By Product

    • Instruments
      • Bioreactors
        • Reusable Bioreactors
        • Single-use Bioreactors
      • Chromatography systems
      • Filtration Systems
      • Other Instruments
        (Note:Other Instruments include shakers, mixers, incubators, sterilizes, centrifuges, bioprocessing containers, among others)
      • Consumables
        • Cell Lines & Media
        • Buffers & Reagents 
        • Chromatography Columns & Resins
        • Other Consumables
          (Note:Other Consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors)
      • Software

    By Antibody Type

    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies

    By Source

    • Mice
    • Rabbit
    • Other sources
      (Note: Other Sources Include Goat, sheep, chicken, and others)

    By Process

    • Upstream
    • Down Stream

    By End User

    • Pharmaceutical & Biotechnology Companies
    • Clinical Research Organisations & Contract Development & Manufacturing Organisations
    • Academic & Research Institutes

    Countries Covered

    North America (U.S., Canada), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LATAM), Middle East & Africa

    Key Companies

    Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.),

    Merck KgaA (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Waters Corporation (U.S.), Shimadzu Corporation (Japan), Solaris Biotechnology Srl (Italy), Infors AG (Switzerland)

    Key Questions Answered in the Report:

    The antibody production market report covers market sizes & forecasts for instruments, consumables, and software. The antibody production market study includes the value analysis of various segments and subsegments of the antibody production market at the regional and country levels.

    The antibody production market is projected to reach $58.35 billion by 2031, at a CAGR of 11.4% from 2024 to 2031.

    The instruments segment is estimated to account for the largest share of the antibody production market in 2024. Moreover, this segment is expected to record the highest CAGR during the forecast period.

    The monoclonal antibodies segment is projected to gain more traction in the antibody production market.

    The high growth of the antibody production market is mainly attributed to the growing demand for targeted antibodies, increasing investments in R&D by pharma & biotech companies, the high burden and growing prevalence of cancer and autoimmune diseases, increasing use of immunoassays, and advancements in bioprocessing technologies.

    Furthermore, growing applications of antibodies in clinical trials and medical research, significant opportunities from developing countries, and growing risk and prevalence of infectious diseases are expected to generate growth opportunities for the players operating in this market.

    The key players operating in the antibody production market are Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Merck KgaA (Germany), Eppendorf SE (Germany), Sartorius AG (Germany), Danaher Corporation (U.S.), Waters Corporation (U.S.), Shimadzu Corporation (Japan), Solaris Biotechnology Srl (Italy), Infors AG (Switzerland)

    The emerging Asian-Pacific countries are expected to offer significant growth opportunities for the vendors in this market due to the growing pharmaceutical and biotech industry, supporting government initiatives, large number of clinical trials conducted in the Asia-Pacific region, and growing demands and biologics for chronic & infectious diseases.

    Enquire
    Check Discount
    COVID-19

    This report provides pre & post COVID-19 market estimates.

    Download sample here
    Related Tag: Antibody Production Market Antibody Manufacturing Immunoglobulin Production Antibody Development MAb Production
    Medical Technologies
    Healthcare

    1. Overview
        1.1. Market Definition & Scope
        1.2. Market Ecosystem
        1.3. Currency & Limitations
        1.4. Key Stakeholders
    2. Research Methodology
        2.1. Research Approach
        2.2. Process of Data Collection and Validation
               2.2.1. Secondary Research
               2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
        2.3. Market Sizing and Forecast
               2.3.1. Market Size Estimation Approach
               2.3.2. Growth Forecast Approach
               2.3.3. Market Share Analysis
        2.4. Assumptions For the Study
    3. Executive Summary
    4. Market Insights
        4.1. Overview
        4.2. Factors Affecting Market Growth
               4.2.1. Market Dynamics
                         4.2.1.1. Drivers
                                      4.2.1.1.1. Growing Demand for Targeted Antibodies
                                      4.2.1.1.2. Increasing Investments In R&D By Pharma & Biotech Companies
                                      4.2.1.1.3. High Burden and Growing Prevalence of Cancer and Autoimmune Diseases
                                      4.2.1.1.4. Increasing Use of Immunoassays
                                      4.2.1.1.5. Advancements In Bioprocessing Technologies
                         4.2.1.2. Restraints
                                      4.2.1.2.1. High Cost of Antibody Production
                                      4.2.1.2.2. Stringent Regulatory Frameworks
                         4.2.1.3. Opportunities
                                      4.2.1.3.1. Growing Applications of Antibodies in Clinical Trials and Medical Research 
                                      4.2.1.3.2. Significant Opportunities from Developing Countries.
                                      4.2.1.3.3. Growing Risk and Prevalence of Infectious Diseases
                         4.2.1.4. Challenges
                                      4.2.1.4.1. Complex Nature of Monoclonal Antibodies 
        4.3. Regulatory Analysis
        4.4. Porter’s Five Forces Analysis
        4.5. Pricing Analysis
    5. Antibody Production Market Assessment—by Product
        5.1. Overview
        5.2. Instruments
               5.2.1. Bioreactors
                         5.2.1.1. Reusable Bioreactors
                         5.2.1.2. Single-use Bioreactors
               5.2.2. Chromatography Systems
               5.2.3. Filtration Systems
               5.2.4. Other Instruments
        5.3. Consumables
               5.3.1. Cell Lines & Media
               5.3.2. Buffers & Reagents
               5.3.3. Chromatography Columns & Resins
               5.3.4. Other Consumables
        5.4. Software
    6. Antibody Production Market Assessment—by Antibody Type
        6.1. Overview
        6.2. Monoclonal Antibodies
        6.3. Polyclonal Antibodies
        6.4. Recombinant Antibodies
    7. Antibody Production Market Assessment—by Source
        7.1. Overview
        7.2. Mice
        7.3. Rabbit
        7.4. Other Sources
    8. Antibody Production Market Assessment—by Process
        8.1. Overview
        8.2. Downstream
        8.3. Upstream
    9. Antibody Production Market Assessment—by End User
        9.1. Overview
        9.2. Pharmaceutical & Biotechnology Companies
        9.3. CROs & CDMOs
        9.4. Academic & Research Institutes
    10. Antibody Production Market Assessment—by Geography
          10.1. Overview
          10.2. North America
                   10.2.1. U.S.
                   10.2.2. Canada
          10.3. Europe
                   10.3.1. Germany
                   10.3.2. France
                   10.3.3. U.K.
                   10.3.4. Italy
                   10.3.5. Spain
                   10.3.6. Rest of Europe
          10.4. Asia-Pacific
                   10.4.1. China
                   10.4.2. India
                   10.4.3. Japan
                   10.4.4. Rest of Asia-Pacific
          10.5. Latin America
                   10.5.1. Brazil
                   10.5.2. Mexico
                   10.5.3. Rest of Latin America
          10.6. Middle East & Africa
    11. Competition Analysis
          11.1. Overview
          11.2. Key Growth Strategies
          11.3. Competitive Benchmarking
          11.4. Competitive Dashboard
                   11.4.1. Industry Leaders
                   11.4.2. Market Differentiators
                   11.4.3. Vanguards
                   11.4.4. Emerging Companies
          11.5. Market Share Analysis/Market Ranking, by Key Players (2022)
    12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
          12.1. Thermo Fisher Scientific, Inc. 
          12.2. Merck KgaA 
          12.3. Eppendorf SE
          12.4. Agilent Technologies, Inc.
          12.5. Sartorius AG
          12.6. Danaher Corporation
          12.7. Waters Corporation
          12.8. Shimadzu Corporation
          12.9. Solaris Biotechnology Srl
          12.10. Infors AG
                     (Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
    13. Appendix
          13.1. Available Customization
          13.2. Related Reports


    List of Tables
    Table 1        Global Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 2        Global Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 3        Global Antibody Production Instruments Market, By Country/Region, 2022–2031 (USD Million)
    Table 4        Global Bioreactors Market for Antibody Production, By Type, 2022–2031 (USD Million)
    Table 5        Global Bioreactors Market for Antibody Production, By Country/Region, 2022–2031 (USD Million)
    Table 6        Global Reusable Bioreactors Market for Antibody Production, By Country/Region, 2022–2031 (USD Million)
    Table 7        Global Single-use Bioreactors Market for Antibody Production, By Country/Region, 2022–2031 (USD Million)
    Table 8        Global Filtration Systems Market for Antibody Production, By Country/Region, 2022–2031 (USD Million)
    Table 9        Global Chromatography Systems Market for Antibody Production, By Country/Region, 2022–2031 (USD Million)
    Table 10        Global Other Instruments Market for Antibody Production, By Country/Region, 2022–2031 (USD Million)
    Table 11        Global Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 12        Global Antibody Production Consumables Market, By Country/Region, 2022–2031 (USD Million)
    Table 13        Global Cell Lines & Media Market, By Country/Region, 2022–2031 (USD Million)
    Table 14        Global Buffers & Reagents Market, By Country/Region, 2022–2031 (USD Million)
    Table 15        Global Chromatography Columns & Resins Market, By Country/Region, 2022–2031 (USD Million)
    Table 16        Global Other Antibody Production Consumables Market, By Country/Region, 2022–2031 (USD Million)
    Table 17        Global Antibody Production Software Market, By Country/Region, 2022–2031 (USD Million)
    Table 18        Global Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 19        Global Monoclonal Antibodies Production Market, By Country/Region, 2022–2031 (USD Million)
    Table 20        Global Polyclonal Antibodies Production Market, By Country/Region, 2022–2031 (USD Million)
    Table 21        Global Recombinant Antibodies Production Market, By Country/Region, 2022–2031 (USD Million)
    Table 22        Global Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 23        Global Antibody Production Market for Mice, By Country/Region, 2022–2031 (USD Million)
    Table 24        Global Antibody Production Market for Rabbit, By Country/Region, 2022–2031 (USD Million)
    Table 25        Global Antibody Production Market for Other Sources, By Country/Region, 2022–2031 (USD Million)
    Table 26        Global Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 27        Global Antibody Production Market for Downstream Process, By Country/Region, 2022–2031 (USD Million)
    Table 28        Global Antibody Production Market for Upstream Process, By Country/Region, 2022–2031 (USD Million)
    Table 29        Global Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 30        Global Antibody Production Market for Pharmaceutical & Biotechnology Companies, By Country/Region, 2022–2031 (USD Million)
    Table 31        Global Antibody Production Market for CROs & CDMOs, By Country/Region, 2022–2031 (USD Million)
    Table 32        Global Antibody Production Market for Academic & Research Institutes, By Country/Region, 2022–2031 (USD Million)
    Table 33        Global Antibody Production Market, By Country/Region, 2022–2031 (USD Million)
    Table 34        North America: Antibody Production Market, By Country, 2022–2031 (USD Million)
    Table 35        North America: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 36        North America: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 37        North America: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 38        North America: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 39        North America: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 40        North America: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 41        North America: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 42        North America: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 43        U.S.: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 44        U.S.: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 45        U.S.: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 46        U.S.: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 47        U.S.: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 48        U.S.: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 49        U.S.: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 50        U.S.: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 51        Canada: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 52        Canada: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 53        Canada: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 54        Canada: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 55        Canada: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 56        Canada: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 57        Canada: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 58        Canada: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 59        Europe: Antibody Production Market, By Country, 2022–2031 (USD Million)
    Table 60        Europe: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 61        Europe: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 62        Europe: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 63        Europe: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 64        Europe: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 65        Europe: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 66        Europe: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 67        Europe: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 68        Germany: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 69        Germany: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 70        Germany: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 71        Germany: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 72        Germany: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 73        Germany: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 74        Germany: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 75        Germany: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 76        France: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 77        France: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 78        France: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 79        France: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 80        France: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 81        France: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 82        France: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 83        France: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 84        U.K.: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 85        U.K.: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 86        U.K.: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 87        U.K.: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 88        U.K.: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 89        U.K.: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 90        U.K.: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 91        U.K.: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 92        Spain: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 93        Spain: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 94        Spain: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 95        Spain: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 96        Spain: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 97        Spain: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 98        Spain: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 99        Spain: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 100    Italy: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 101    Italy: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 102    Italy: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 103    Italy: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 104    Italy: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 105    Italy: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 106    Italy: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 107    Italy: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 108    RoE: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 109    RoE: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 110    RoE: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 111    RoE: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 112    RoE: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 113    RoE: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 114    RoE: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 115    RoE: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 116    Asia-Pacific: Antibody Production Market, By Country/Region, 2022–2031 (USD Million)
    Table 117    Asia-Pacific: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 118    Asia-Pacific: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 119    Asia-Pacific: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 120    Asia-Pacific: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 121    Asia-Pacific: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 122    Asia-Pacific: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 123    Asia-Pacific: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 124    Asia-Pacific: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 125    China: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 126    China: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 127    China: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 128    China: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 129    China: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 130    China: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 131    China: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 132    China: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 133    Japan: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 134    Japan: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 135    Japan: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 136    Japan: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 137    Japan: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 138    Japan: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 139    Japan: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 140    Japan: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 141    RoAPAC: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 142    RoAPAC: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 143    RoAPAC: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 144    RoAPAC: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 145    RoAPAC: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 146    RoAPAC: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 147    RoAPAC: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 148    RoAPAC: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 149    Latin America: Antibody Production Market, By Country, 2022–2031 (USD Million)
    Table 150    Latin America: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 151    Latin America: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 152    Latin America: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 153    Latin America: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 154    Latin America: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 155    Latin America: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 156    Latin America: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 157    Latin America: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 158    Brazil: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 159    Brazil: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 160    Brazil: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 161    Brazil: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 162    Brazil: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 163    Brazil: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 164    Brazil: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 165    Brazil: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 166    Mexico: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 167    Mexico: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 168    Mexico: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 169    Mexico: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 170    Mexico: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 171    Mexico: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 172    Mexico: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 173    Mexico: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 174    RoLATAM: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 175    RoLATAM: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 176    RoLATAM: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 177    RoLATAM: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 178    RoLATAM: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 179    RoLATAM: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 180    RoLATAM: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 181    RoLATAM: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 182    Middle East & Africa: Antibody Production Market, By Product, 2022–2031 (USD Million)
    Table 183    Middle East & Africa: Antibody Production Instruments Market, By Type, 2022–2031 (USD Million)
    Table 184    Middle East & Africa: Bioreactors for Antibody Production Market, By Type, 2022–2031 (USD Million)
    Table 185    Middle East & Africa: Antibody Production Consumables Market, By Type, 2022–2031 (USD Million)
    Table 186    Middle East & Africa: Antibody Production Market, By Antibody Type, 2022–2031 (USD Million)
    Table 187    Middle East & Africa: Antibody Production Market, By Source, 2022–2031 (USD Million)
    Table 188    Middle East & Africa: Antibody Production Market, By Process, 2022–2031 (USD Million)
    Table 189    Middle East & Africa: Antibody Production Market, By End User, 2022–2031 (USD Million)
    Table 190    Recent Developments, By Company, 2020-2023


    List of Figures
    Figure 1    Research Process
    Figure 2    Secondary Sources Referenced for This Study
    Figure 3    Primary Research Techniques
    Figure 4    Key Executives Interviewed
    Figure 5    Breakdown of Primary Interviews (Supply Side & Demand Side)
    Figure 6    Market Sizing and Growth Forecast Approach
    Figure 7    Global Antibody Production Market, By Product, 2024 Vs. 2031 (USD Million)
    Figure 8    Global Antibody Production Market, By Antibody Type, 2024 Vs. 2031 (USD Million)
    Figure 9    Global Antibody Production Market, By Source, 2024 Vs. 2031 (USD Million)
    Figure 10    Global Antibody Production Market, By Process, 2024 Vs. 2031 (USD Million)
    Figure 11    Global Antibody Production Market, By End User, 2024 Vs. 2031 (USD Million)
    Figure 12    Global Antibody Production Market, By Geography
    Figure 13    Impact Analysis of Market Dynamics
    Figure 14    Global Antibody Production Market, By Product, 2024 Vs. 2031 (USD Million)
    Figure 15    Global Antibody Production Market, By Antibody Type, 2024 Vs. 2031 (USD Million)
    Figure 16    Global Antibody Production Market, By Source, 2024 Vs. 2031 (USD Million)
    Figure 17    Global Antibody Production Market, By Process, 2024 Vs. 2031 (USD Million)
    Figure 18    Global Antibody Production Market, By End User, 2024 Vs. 2031 (USD Million)
    Figure 19    Global Antibody Production Market, By Geography, 2024 Vs. 2031 (USD Million)
    Figure 20    North America: Antibody Production Market Snapshot
    Figure 21    Europe: Antibody Production Market Snapshot    
    Figure 22    Asia-Pacific: Antibody Production Market Snapshot
    Figure 23    Latin America: Antibody Production Market Snapshot
    Figure 24    Key Growth Strategies Adopted by Leading Players (2021–2024)
    Figure 25    Antibody Production Market: Competitive Benchmarking, By Product
    Figure 26    Antibody Production Market: Competitive Benchmarking, By Region
    Figure 27    Competitive Dashboard Antibody Production Market
    Figure 28    Global Antibody Production Market Share Analysis, By Key Players, 2023
    Figure 29    Thermo Fisher Scientific, Inc.: Financial Overview (2023)
    Figure 30    Merck KgaA.: Financial Overview (2023)
    Figure 31    Eppendorf SE: Financial Overview (2023)
    Figure 32    Agilent Technologies, Inc.: Financial Overview (2023)
    Figure 33    Sartorius AG: Financial Overview (2023)
    Figure 34    Danaher Corporation: Financial Overview (2023)
    Figure 35    Waters Corporation: Financial Overview (2023)
    Figure 36    Shimadzu Corporation: Financial Overview (2023)

    Enquire
    Check Discount
    COVID-19

    This report provides pre & post COVID-19 market estimates.

    Download sample here
    Related Tag: Antibody Production Market Antibody Manufacturing Immunoglobulin Production Antibody Development MAb Production
    Medical Technologies
    Healthcare
      This website is secure and we do not share your personal information with any third party. privacy policy
      COVID-19

      This report provides pre & post COVID-19 market estimates.

      Related Tag: Antibody Production Market Antibody Manufacturing Immunoglobulin Production Antibody Development MAb Production
      Request Sample
      Customize My Report
      Linkdin
      Whatsapp
      Feed
      Related Reports
      Downstream Processing In Bio- pharmaceuticals

         Published Date: Sep-2013

      COVID-19 Diagnostics and Therapy Market - Opportunity Assessment and Global Forecast 2025

         Published Date: Jul-2020

      Cell Culture Media Market - Global Opportunity Analysis and Industry Forecast (2022-2029)

         Published Date: Jul-2022

      Cell Culture Reagents Market - Global Opportunity Analysis and Industry Forecast (2022-2029)

         Published Date: Jul-2022

      Biopharmaceutical Processing Equipment and Consumables Market - Global Opportunity Analysis and Industry Forecast (2024-2031)

         Published Date: Aug-2024

      Table Of Content
      Download Free Sample Report
      Meticulous Research
      US
      +1 646-781-8004
      Meticulous Research
      Europe
      +44-203-868-8738
      Meticulous Research
      APAC
      +91-744-778-0008